Dipeptidyl peptidase 4 — Drug Target

All drugs that target Dipeptidyl peptidase 4 — marketed and clinical-stage. Includes 5 drug classes acting on this target.

Drug classes

Dipeptidyl Peptidase 4 Inhibitor [EPC] · vildagliptin · vidarabine · gemigliptin · Dipeptidyl Peptidase 4 Inhibitor

Marketed (9)

• Januvia · Zydus Lifesciences · Dipeptidyl Peptidase 4 Inhibitor [EPC] · Metabolic
  Januvia works by blocking an enzyme that breaks down hormones that help the body release insulin.
• Tradjenta · Boehringer Ingelheim · Dipeptidyl Peptidase 4 Inhibitor [EPC] · Metabolic
  Tradjenta works by blocking the DPP-4 enzyme, which normally breaks down incretin hormones that help regulate blood sugar levels.
• Tradjenta · Boehringer Ingelheim · Dipeptidyl Peptidase 4 Inhibitor [EPC] · Metabolic
  Tradjenta works by blocking an enzyme that breaks down hormones that help the body release insulin.
• Jalra · vildagliptin · Metabolic
• Suganon · Dong-A ST · Metabolic
• Vidarabin · vidarabine · Infectious Disease
• Zemiglo · gemigliptin · Metabolic
• Suiny · Metabolic
• Nesina · Takeda · Dipeptidyl Peptidase 4 Inhibitor · Metabolic
  Nesina works by blocking an enzyme that breaks down incretin hormones, allowing more insulin to be released and less glucagon.